EYEDURA’S SUSTAINED-RELEASE EYE DROP TECHNOLOGY WINS DOUBLE INDUSTRY HONORS
Sustained-released platform has the potential to deliver therapeutic levels for seven days and beyond, addressing key treatment challenges in eye care NEW YORK — July 15, 2025 — (Business Wire) EyeDura Therapeutics Inc. (www.eyedura.com), a developer of preservative-free sustained release ophthalmic therapies, announced that it received top recognition at two major industry forums among a […]